[Multiple myeloma nephropathy as a cause of renal failure--diagnostic difficulties and prospects for treatment].
We describe two patients admitted to our hospital because of renal failure. We diagnosed multiple myeloma in both. One patient had high peripheral blood eosinophilia, that normalized during therapy. The patients were treated with melphalan and prednisone, hemodialysis and one patient with recombinant human erythropoietin. Both patients responded to that treatment: after 7 months the number of plasma cell in bone marrow decreased from 65 to 10% in the first patient, and from 38 to 4% in the second patient. They returned to work and were on maintenance hemodialysis 2 times weekly. The patients have been observed for 21 months.
Polak
G
G
Katedra i Klinika Kardiologii i Chorób Wewnetrznych Akademii Medycznej w Bydgoszczy.
Tomczak-Watras
W
W
Nartowicz
E
E
D000368:Aged; D004921:Erythropoietin / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008558:Melphalan / Q000627:therapeutic use; D008875:Middle Aged; D009101:Multiple Myeloma / Q000150:complications*; D011241:Prednisone / Q000627:therapeutic use; D011994:Recombinant Proteins; D006435:Renal Dialysis; D051437:Renal Insufficiency / Q000175:diagnosis* / Q000209:etiology* / Q000628:therapy; D016896:Treatment Outcome
D011994:Recombinant Proteins; D004921:Erythropoietin; D008558:Melphalan; D011241:Prednisone